Your browser doesn't support javascript.
loading
A three-microRNA signature predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma.
Saito, Motonobu; Shiraishi, Kouya; Matsumoto, Kenji; Schetter, Aaron J; Ogata-Kawata, Hiroko; Tsuchiya, Naoto; Kunitoh, Hideo; Nokihara, Hiroshi; Watanabe, Shun-Ichi; Tsuta, Koji; Kumamoto, Kensuke; Takenoshita, Seiichi; Yokota, Jun; Harris, Curtis C; Kohno, Takashi.
Afiliación
  • Saito M; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan. Department of Organ Regulatory Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Matsumoto K; Department of Allergy and Immunology, National Research Institute for Child Health and Development, Setagaya, Tokyo, Japan.
  • Schetter AJ; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Ogata-Kawata H; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Tsuchiya N; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Kunitoh H; Department of Medical Oncology, Japanese Red Cross Medical Center, National Cancer Center Hospital, Tokyo, Japan.
  • Nokihara H; Division of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Watanabe S; Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Tsuta K; Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Kumamoto K; Department of Organ Regulatory Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Takenoshita S; Department of Organ Regulatory Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Yokota J; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan. Cancer Genome Biology, Institute of Predictive and Personalized Medicine of Cancer, Barcelona, Spain.
  • Harris CC; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan. tkkohno@ncc.go.jp.
Clin Cancer Res ; 20(18): 4784-93, 2014 Sep 15.
Article en En | MEDLINE | ID: mdl-25142144
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Compuestos de Platino / MicroARNs / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Compuestos de Platino / MicroARNs / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos